Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.
about
Fungal allergy in asthma-state of the art and research needsAllergic Bronchopulmonary Aspergillosis: A Perplexing Clinical EntityAirway fibrinogenolysis and the initiation of allergic inflammationAzole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Isavuconazole: Case Report and Review of the LiteratureSuccessful long-term terbinafine therapy in an asthmatic patient with Aspergillus sensitization and bronchiectasis.Airway surface mycosis in chronic TH2-associated airway disease.Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis.Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview.Fungal rhinosinusitis: what every allergist should know.Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review.Burden and distinctive character of allergic bronchopulmonary aspergillosis in India.Allergic bronchopulmonary aspergillosis: A clinical review of 24 patients: Are we right in frequent serologic monitoring?Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review.Antibody testing in aspergillosis--quo vadis?Republished: The clinical spectrum of pulmonary aspergillosis.The spectrum of allergic fungal diseases of the upper and lower airways.Airway Microbiota and the Implications of Dysbiosis in Asthma.Are allergic fungal rhinosinusitis and allergic bronchopulmonary aspergillosis lifelong conditions?Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.Allergic bronchopulmonary aspergillosis in asthma: epidemiological, clinical and therapeutic issues.Burden of serious fungal infections in Trinidad and Tobago.Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA).Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern?Can Controlling Endoplasmic Reticulum Dysfunction Treat Allergic Inflammation in Severe Asthma With Fungal Sensitization?Environmental fungicides and triazole resistance in Aspergillus.Benefits of antifungal therapy in asthma patients with airway mycosis: A retrospective cohort analysis.Pattern recognition pathways leading to a Th2 cytokine bias in allergic bronchopulmonary aspergillosis patients.What is the current place of azoles in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization
P2860
Q22001138-B3060206-D63F-4439-9EAB-F8ADBE6C584BQ26749101-D959553D-8EFA-48D4-8275-F68984A0E041Q26851613-CBC8052C-5398-4541-8062-4323CFF1ABDFQ28082352-69BFC8DB-8384-4D06-B60E-54E295CF36EEQ33641883-03CAF8DF-3EFE-4E3E-86E4-7712C9C40CE2Q33811949-D32AE1A0-E646-4F06-9EF8-D3A4505590C6Q33993743-8A502185-6E5C-418E-AEAA-F4CE4A831491Q35947796-6A428CD7-B105-4AB3-8B00-432E3548B5D2Q37111641-9A25FBF8-B09A-416D-97EB-6D224376205EQ38079263-DF2AE6DF-A830-46AB-8626-3F31B4C7C797Q38124365-E793E6DC-8315-445A-8C5F-5FC46B404A46Q38210276-31ABD97D-95CB-4C20-8D2B-21F7192E58ECQ38221676-7E023441-3FBB-4C26-9B9A-75A24E589549Q38256151-ABB19693-16A4-45A9-982A-55D7603A1390Q38359303-BE6A3563-C28E-4E59-8497-E196F90447F0Q38484090-881C7AA7-2CEA-4932-835C-4DD20FCBC8A8Q38549796-FE652A06-A308-4DD8-8014-FC01F38E38F1Q38699838-07FCEC11-C1A5-417F-AA72-D937E61B0509Q38890722-1D2BD1D4-1DCB-4967-8AAC-F25957876F74Q38948097-F04332F9-5874-4055-981A-5A5A92420177Q39282119-85CBCE58-7E4E-44BD-8E36-4EEB50049827Q39319765-227277F0-DC3C-4840-9EA5-6E33F38815B3Q40960959-5F9C8AE2-BDF9-4A92-828D-5DADC82B248DQ45997955-D58F5526-7B6E-40CC-B479-A0D18A2D80F9Q47850725-75541F07-5658-462D-945D-11B78324E64EQ50144888-EF3B0843-7E85-4C12-971B-8FFC07844ACFQ51042801-07542F3A-7B4A-4EB9-851A-4487354AA1A7Q51735192-AEFB0170-4B96-4B0F-8556-4E2BFB32FBB9Q53146228-EC6A0CA4-BBFC-4217-ADC5-A3A09B214862Q57749749-738043C4-0AEC-4061-AB2B-8CA34189A0DE
P2860
Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Voriconazole and posaconazole ...... hma with fungal sensitization.
@en
Voriconazole and posaconazole ...... hma with fungal sensitization.
@nl
type
label
Voriconazole and posaconazole ...... hma with fungal sensitization.
@en
Voriconazole and posaconazole ...... hma with fungal sensitization.
@nl
prefLabel
Voriconazole and posaconazole ...... hma with fungal sensitization.
@en
Voriconazole and posaconazole ...... hma with fungal sensitization.
@nl
P2860
P921
P1433
P1476
Voriconazole and posaconazole ...... hma with fungal sensitization.
@en
P2093
John Cooley
Livingstone Chishimba
P2860
P304
P356
10.3109/02770903.2012.662568
P407
P577
2012-03-02T00:00:00Z